SoftOx Solutions AS will release the first quarter 2022 results on Thursday 28th
April 2022 at 07:00 CET.
At 10:00 CET on the same day, the management will host a webcast to present the
results. Following the presentation, there will be a Q&A session where written
questions can be submitted to firstname.lastname@example.org.
The webcasted presentation will be in Norwegian. To join, please use the link
that is available at https://soft-ox.com/investor-presentations/.
A recording will be available shortly after the presentation has finished.
For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Kristine Rød, CFO at SoftOx Solutions AS
Phone: Front Desk: (+47) 948-59-599
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
medtech/biotech company based in Oslo with the aim of helping to combat major
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com